Interoperable data systems can improve cancer care

Cancer centers today are facing growing pressure from stakeholders across the cancer care and research community to meet data-driven expectations. Yet many centers continue to rely on fragmented, siloed data systems that ...

What's next for GLP-1s?

Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other chronic diseases—many with few treatment ...

page 11 from 40